Boston plows on with renal denervation with new Vessix trial design
This article was originally published in Clinica
Executive Summary
Boston Scientific hasn’t given up on renal denervation, and has even started a new study of its Vessix device. It will be hoping that the “novel design” will show a positive effect with the controversial therapy.